A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002072
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Cytopenias
Interventions
DRUG:
Epoetin alfa
Sponsor
Ortho Pharmaceuticals